Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-25 @ 1:34 AM
NCT ID:
NCT07215494
Eligibility Criteria:
Inclusion Criteria:
1. Age range: 18-70 years (inclusive), no gender restriction;
2. Newly diagnosed AL amyloidosis patients;
3. Meet ASCT eligibility criteria and have a willingness to undergo ASCT;
4. Achieved hematological complete response (CR) after 2-4 cycles of Dara-CyBorD induction chemotherapy.
Exclusion Criteria:
1. Secondary to multiple myeloma or lymphoplasmacytic lymphoma, such as Waldenström's macroglobulinemia;
2. Co-existing other active malignant tumors;
3. Co-existing other systemic diseases deemed unsuitable for inclusion by the investigator, such as newly developed severe cardiovascular and cerebrovascular diseases, or severe infections.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT07215494
Study Brief:
Protocol Section:
NCT07215494